Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
September 27, 2025
Response to Letter Re: Dose-individualisation of fluoropyrimidines based on pre-treatment serum uracil levels
Niels Heersche, Ron H J Mathijssen, Annemieke Cats, et al.
Clinical Chemistry and Laboratory Medicine
|
July 18, 2024
Is uracil enough for effective pre-emptive DPD testing?
Niels Heersche, Maja Matic, Ron H J Mathijssen, et al.
Cancer Treatment Reviews
|
December 3, 2023
Review - The impact of pharmacogenetics on the outcome of immune checkpoint inhibitors
Karlijn de Joode, Niels Heersche, Edwin A Basak, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
April 15, 2022
Clinical implications of germline variations for treatment outcome and drug resistance for small molecule kinase inhibitors in patients with non-small cell lung cancer
Niels Heersche, G D Marijn Veerman, Mirjam de With, et al.
Clinical Pharmacology and Therapeutics
|
October 16, 2021
Effect of the Proton Pump Inhibitor Esomeprazole on the Systemic Exposure of Capecitabine: Results of A Randomized Crossover Trial
Leni van Doorn, Niels Heersche, Femke M de Man, et al.
Genes
|
April 2, 2020
Influence of Genetic Variation in <i>COMT</i> on Cisplatin-Induced Nephrotoxicity in Cancer Patients
Bram C Agema, Stijn L W Koolen, Mirjam de With, et al.
JCO Precision Oncology
|
June 8, 2026
Pharmacokinetics of 5-Fluorouracil in Patients Treated With Capecitabine Carrying the c.1236G>A <i>DPYD</i> Variant Allele
Niels Heersche, Jonathan E Knikman, Maarten J Deenen, et al.
Cancer Communications (London, England)
|
May 1, 2025
Semaglutide impairs bioavailability of alectinib: a note of warning based on a cross-over pharmacokinetic drug-drug interaction study
Niels Heersche, Daan A C Lanser, Esther Oomen-de Hoop, et al.
Frontiers in Pharmacology
|
December 3, 2021
Tissue Type Differences in ABCB1 Expression and Paclitaxel Tissue Pharmacokinetics in Patients With Esophageal Cancer
Ruben A G van Eerden, Leni van Doorn, Femke M de Man, et al.
Cancer Communications (London, England)
|
May 25, 2026
Sex Impacts Progression-Free Survival of Alectinib through Drug Exposure in Patients with <i>ALK-</i>Positive Non-Small Cell Lung Cancer
Daan A C Lanser, Niels Heersche, M Benthe Muntinghe-Wagenaar, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
European Journal of Cancer (Oxford, England : 1990)
|
September 27, 2025
Response to Letter Re: Dose-individualisation of fluoropyrimidines based on pre-treatment serum uracil levels
Niels Heersche, Ron H J Mathijssen, Annemieke Cats, et al.
Clinical Chemistry and Laboratory Medicine
|
July 18, 2024
Is uracil enough for effective pre-emptive DPD testing?
Niels Heersche, Maja Matic, Ron H J Mathijssen, et al.
Cancer Treatment Reviews
|
December 3, 2023
Review - The impact of pharmacogenetics on the outcome of immune checkpoint inhibitors
Karlijn de Joode, Niels Heersche, Edwin A Basak, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
April 15, 2022
Clinical implications of germline variations for treatment outcome and drug resistance for small molecule kinase inhibitors in patients with non-small cell lung cancer
Niels Heersche, G D Marijn Veerman, Mirjam de With, et al.
Clinical Pharmacology and Therapeutics
|
October 16, 2021
Effect of the Proton Pump Inhibitor Esomeprazole on the Systemic Exposure of Capecitabine: Results of A Randomized Crossover Trial
Leni van Doorn, Niels Heersche, Femke M de Man, et al.
Genes
|
April 2, 2020
Influence of Genetic Variation in <i>COMT</i> on Cisplatin-Induced Nephrotoxicity in Cancer Patients
Bram C Agema, Stijn L W Koolen, Mirjam de With, et al.
JCO Precision Oncology
|
June 8, 2026
Pharmacokinetics of 5-Fluorouracil in Patients Treated With Capecitabine Carrying the c.1236G>A <i>DPYD</i> Variant Allele
Niels Heersche, Jonathan E Knikman, Maarten J Deenen, et al.
Cancer Communications (London, England)
|
May 1, 2025
Semaglutide impairs bioavailability of alectinib: a note of warning based on a cross-over pharmacokinetic drug-drug interaction study
Niels Heersche, Daan A C Lanser, Esther Oomen-de Hoop, et al.
Frontiers in Pharmacology
|
December 3, 2021
Tissue Type Differences in ABCB1 Expression and Paclitaxel Tissue Pharmacokinetics in Patients With Esophageal Cancer
Ruben A G van Eerden, Leni van Doorn, Femke M de Man, et al.
Cancer Communications (London, England)
|
May 25, 2026
Sex Impacts Progression-Free Survival of Alectinib through Drug Exposure in Patients with <i>ALK-</i>Positive Non-Small Cell Lung Cancer
Daan A C Lanser, Niels Heersche, M Benthe Muntinghe-Wagenaar, et al.
Page
of 2